Search Results 391-400 of 13530 for Birth Control Palette

1. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

   Patients with reproductive potential must agree to use at least one form of barrier contraception prior to study entry and for up to 30 days beyond the last ...

2. Mayo Clinic Pediatric Cardiology and Cardiovascular Surgery

   Approximately one in a 100 live births have a congenital heart defect, so it's really one of the most common congenital birth defects. And the good news for ...

3. Collection of Blood Samples from a Population at Low Risk for HIV Infection - Mayo Clinic

   About this study. The objective of this protocol is to collect EDTA-plasma and serum samples from adult subjects at low-risk for HIV infection.

4. A Study to Evaluate the Effectiveness and Safety of DA-1229 (Evogliptin) in Delaying Progression of Mild or Moderate Calcific Aortic Stenosis (EVOID-AS trial) - Mayo Clinic

   Women of childbearing potential should use an approved method of birth control ... * Acceptable methods of contraception include abstinence, female subject/ ...

5. Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Women of childbearing potential who do not agree to practice 2 different methods of birth control or remain abstinent during the trial and for 30 days after the ...

6. Nizubaglusta in Late-Infantile and Juvenile Forms of Niemann-Pick Type C Disease and GM1 Gangliosidosis or GM2 Gangliosidosis - Mayo Clinic

   ... contraception associated with inhibition of ovulation (oral, injectable, or ... contraceptive methods listed in inclusion criterion 8. Non-vasectomized ...

7. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies ...

8. A Study to Evaluate Genetic Testing in Guiding Treatment for Patients with Brain Metastases - Mayo Clinic

   Note: this includes patients that have controlled ... contraception method during the treatment period ... Contraceptive methods may include an intrauterine device ...

9. Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome - Mayo Clinic

   Lactation, pregnancy, or refusal of birth control in females with child-bearing potential; Planned treatment with live or live-attenuated vaccines once ...

10. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

    ... birth to < 2 years of age: to be determined. Male participants: A male participant with a female partner of childbearing potential must agree to use ...